Korean J Dermatol.
2011 Jul;49(7):656-659.
Granuloma Annulare Induced by Adalimumab
- Affiliations
-
- 1Department of Dermatology, Hanyang University College of Medicine, Seoul, Korea. drko0303@hanyang.ac.kr
Abstract
- Adalimumab is the first fully humanized monoclonal anti-tumor necrosis factor alpha (TNF-alpha) antibody. This drug has been shown to be of benefit in patients with inflammatory diseases in which TNF-alpha is involved, such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and Crohn's disease. As the use of adalimumab is becoming more widespread, cutaneous side effects are being increasingly reported. Various dermatologic adverse events have been reported in the literature, including injection site reactions, psoriasis-like eruption and pityriasis rosea. Herein, we describe a case of GA associated with adalimumab treatment for adult-onset Still's disease, which has not been reported in Korea.
Keyword
MeSH Terms
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Two Cases of Generalized Granuloma Annulare in Early Childhood
- Generalized Actinic Granuloma annulare with Impaired Glucose Tolerance Test
- Anetoderma due to Generalized Perforating Granuloma Annulare
- A Case of Generalized Granuloma Annulare That Clinically Presented as Erythema Annulare Centrifugum
- A Case of HIV-associated Granuloma Annulare
